Last reviewed · How we verify
NCT03894462
Study About Treatment After a Suicide Attempt
NA trial testing Attempted Suicide Short Intervention Program in Suicide, Attempted in 443 participants. Completed in 1 April 2025.
1 April 2025
Quick facts
| Lead sponsor | University of Rochester |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 443 |
| Start date | 1 April 2021 |
| Primary completion | 1 April 2025 |
| Estimated completion | 1 April 2025 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Attempted Suicide Short Intervention Program
- Zero Suicide Usual Care
Conditions studied
- Suicide, Attempted — all drugs for Suicide, Attempted →
Sponsor
University of Rochester
Who can join
18 and older, any sex, with Suicide, Attempted. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Effective, brief, low-cost interventions for individuals who attempt suicide are needed to save lives and achieve the goals of the National Strategy for Suicide Prevention. In response to a National Institute for Mental Health (NIMH) Notice of Interest, this time-sensitive proposal leverages an existing federal investment in Zero Suicide to test the effectiveness of a highly promising new treatment for recent suicide attempt survivors and learn how it works. If hypotheses are supported, the study will provide evidence of a brief, practical, and cost-effective therapy that reduces suicide reattempts in a real-world health setting.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Psychosocial interventions for self-harm in adults.
Witt KG, Hetrick SE, Rajaram G, Hazell P, et al · · 2021 · cited 79× · PMID 33884617 · DOI 10.1002/14651858.cd013668.pub2 -
Effectiveness of a targeted brief intervention for recent suicide attempt survivors: a randomised controlled trial protocol.
Pisani A, Connor K, Van Orden K, Jordan N, et al · · 2023 · cited 2× · PMID 36868590 · DOI 10.1136/bmjopen-2022-070105
Verify or expand the search:
- PubMed search for NCT03894462
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Suicide, Attempted
Currently open trials in the same condition.
- NCT07219355 — Virtual Reality Lethal Means Safety Training · NA · recruiting
- NCT07395752 — Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study · NA · recruiting
- NCT06151158 — Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings · NA · recruiting
- NCT06474221 — Efficacy of EBPSI on Future Suicide Risk Among Adolescent Suicide Attempters · NA · recruiting
- NCT06248268 — Neuropsychological Patterns of Suicide Ideators and Suicide Attempters · recruiting
Other University of Rochester trials
Trials by the same sponsor.
- NCT07075965 — Calcium Channel Blocker in Myotonic Dystrophy Type 1 · Phase 1 · not yet recruiting
- NCT07423104 — A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloi · Phase 2 · not yet recruiting
- NCT05744869 — SBAT for Health Equity · NA · not yet recruiting
- NCT06052956 — Efficacy of Methylene Blue Photodynamic Therapy for Treatment of Deep Tissue Abscesses · Phase 2 · not yet recruiting
- NCT07032636 — Reducing Crises and Suicide Within the Idaho Army National Guard · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03894462 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Rochester
- Last refreshed: 6 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03894462.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing